A Survey of Naturally Occurring Molecules as New Endoplasmic Reticulum Stress Activators with Selective Anticancer

Daniela Correia da Silva1, Patrícia Valentão1, David M Pereira1

  • 1REQUIMTE/LAQV, Laboratório de Farmacognosia, Departamento de Química, Faculdade de Farmácia, Universidade do Porto, Rua de Jorge Viterbo Ferreira, N° 228, 4050-213 Porto, Portugal.

Cancers
|January 8, 2023
PubMed

Insights

Natural products targeting endoplasmic reticulum (ER) stress show selective toxicity against cancer cells. Berberine and emodin are promising leads for developing novel anticancer agents by disrupting cancer cell homeostasis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Neoplastic diseases are a leading cause of death globally, with cancer treatment success rates still limited.
  • Malignant cells possess vulnerabilities, including endoplasmic reticulum (ER) stress, which can be exploited for targeted therapies.

Purpose of the Study:

  • To identify natural products that induce ER stress and exhibit selective toxicity against cancer cell lines.
  • To investigate the mechanisms underlying the cytotoxic effects of these natural products, focusing on ER stress and the unfolded protein response (UPR).

Main Methods:

  • Screening of an in-house chemical library for molecules selectively toxic to cancer cells (AGS and A549) but not non-cancer cells.
  • Assessing the involvement of ER stress and UPR in the cytotoxic effects of active compounds.
  • Evaluating the impact of lead compounds on calcium (Ca2+) homeostasis, UPR gene expression, and ER-resident caspase-4 activation.

Main Results:

  • Several natural products demonstrated selective cytotoxicity against cancer cell lines, primarily through ER stress induction.
  • Berberine emerged as a highly promising compound, showing activity against both gastric and lung adenocarcinoma cell lines.
  • Berberine was found to disrupt Ca2+ homeostasis, induce UPR target gene expression, and activate ER-resident caspase-4.

Conclusions:

  • Natural products can be effective ER stress inducers with selective anticancer properties.
  • Berberine and emodin show significant potential as lead compounds for developing novel, selective anticancer agents that leverage ER stress pathways.

Related Concept Videos

Role of ER in the Secretory Pathway01:17

Role of ER in the Secretory Pathway

Eukaryotic cells have a special pathway that enables communication between various intracellular membrane-bound compartments and also with the extracellular environment. This pathway is termed as the secretory pathway.
Components of the secretory pathway
About a third of proteins synthesized in the cell are sorted via the secretory route. They shuffle between different compartments in membrane-bound vesicles until they reach their final destination. The main intracellular compartments involved...
5.5K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.7K